We initiated the investigation by assessing CDK1 levels in both ovarian cancer and normal ovarian epithelial cells, revealing an elevated expression of CDK1 in ovarian cancer cells (Figure S3A). This evidence concerns the gene CDK1 and ovarian carcinoma.